These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3897068)

  • 1. Attempted treatment of fulminant viral hepatitis with human fibroblast interferon.
    Milazzo F; Galli M; Fassio PG; Cargnel A; Pugliese A; Tovo PA; Vigevani GM; Esposito R; Lazzarin A; Caredda F
    Infection; 1985; 13(3):130-3. PubMed ID: 3897068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis.
    Sánchez-Tapias JM; Mas A; Costa J; Bruguera M; Mayor A; Ballesta AM; Compernolle C; Rodés J
    J Hepatol; 1987 Oct; 5(2):205-10. PubMed ID: 3693864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 4. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of viral hepatitis. b) Anti-virus agents].
    Matsushima T
    Hokkaido Igaku Zasshi; 1984 May; 59(3):238-44. PubMed ID: 6479842
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of delta infection on severity of hepatitis B.
    Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
    Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon treatment in acute progressive and fulminant hepatitis.
    Levin S; Leibowitz E; Torten J; Hahn T
    Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
    Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
    Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects.
    Omata M; Imazeki F; Yokosuka O; Ito Y; Uchiumi K; Mori J; Okuda K
    Gastroenterology; 1985 Apr; 88(4):870-80. PubMed ID: 3972231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
    Saracco G; Mazzella G; Rosina F; Cancellieri C; Lattore V; Raise E; Rocca G; Giorda L; Verme G; Gasbarrini G
    Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha interferon therapy in patients with hepatitis infection undergoing organ transplantation.
    Mancini C; Gaeta A; Lorino G; Filadoro F; Marinucci G; Bachetoni A; Pretagostini R; Molajoni ER; Alfani D; Cortesini R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2429-30. PubMed ID: 2652794
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin.
    Bensabath G; Hadler SC; Soares MC; Fields H; Dias LB; Popper H; Maynard JE
    JAMA; 1987 Jul 24-31; 258(4):479-83. PubMed ID: 3599343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the interferon status of patients with viral hepatitis B when genetically engineered alpha 2-interferon is used].
    Pokrovskiĭ VI; Malinovskaia VV; Murzabaeva RT; Vasil'eva VI; Asratian AA
    Vopr Virusol; 1990; 35(2):135-8. PubMed ID: 2117831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
    Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
    Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis B.
    Hayashi J; Noguchi A; Nakashima K; Hayashi S; Kashiwagi S; Mayumi T; Motomura M
    Clin Ther; 1990; 12(1):12-21. PubMed ID: 2328524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
    Hoofnagle JH; Peters M; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Hallahan C; Park Y; Meschievitz C; Jones EA
    Gastroenterology; 1988 Nov; 95(5):1318-25. PubMed ID: 3049216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.